Related references
Note: Only part of the references are listed.Regulation of the actin cytoskeleton in cancer cell migration and invasion
Hideki Yamaguchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients
S. Charrier et al.
GENE THERAPY (2007)
The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells
Michel H. Maillard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells
Francesco Marangoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The expression of Wiskott-Aldrich syndrome protein (WASP) is dependent on WASP-interacting protein (WIP)
Akihiro Konno et al.
INTERNATIONAL IMMUNOLOGY (2007)
Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis
Stephanie Humblet-Baron et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP)
Miguel A. de la Fuente et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma
Lian-Yue Yang et al.
CLINICAL CANCER RESEARCH (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung
S Semba et al.
CLINICAL CANCER RESEARCH (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation
L Dupré et al.
HUMAN GENE THERAPY (2006)
Regulation of cancer cell motility through actin reorganization
D Yamazaki et al.
CANCER SCIENCE (2005)
Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences
F Martín et al.
GENE THERAPY (2005)
Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein
S de Noronha et al.
BLOOD (2005)
Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages
A Konno et al.
BLOOD (2004)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect
A Gismondi et al.
BLOOD (2004)
The multiple facets of hematopoietic stem cells
RJ Chan et al.
CURRENT NEUROVASCULAR RESEARCH (2004)
Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies
MG Toscano et al.
GENE THERAPY (2004)
Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction
L Dupré et al.
MOLECULAR THERAPY (2004)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
Podosomes: adhesion hot-spots of invasive cells
S Linder et al.
TRENDS IN CELL BIOLOGY (2003)
Transplanted bone marrow regenerates liver by cell fusion
G Vassilopoulos et al.
NATURE (2003)
WASp in immune-system organization and function
AJ Thrasher
NATURE REVIEWS IMMUNOLOGY (2002)
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
A Aiuti et al.
SCIENCE (2002)
High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter
C Demaison et al.
HUMAN GENE THERAPY (2002)
Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells
Y Cui et al.
BLOOD (2002)
Human decidual stromal cells express CD34 and STRO-1 and are related to bone marrow stromal precursors
JM García-Pacheco et al.
MOLECULAR HUMAN REPRODUCTION (2001)
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors
F Moreau-Gaudry et al.
BLOOD (2001)
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility
SB Snapper et al.
NATURE CELL BIOLOGY (2001)
Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation
S Burns et al.
BLOOD (2001)
Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes
S Neil et al.
JOURNAL OF VIROLOGY (2001)
Cutting edge: The Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells
Y Leverrier et al.
JOURNAL OF IMMUNOLOGY (2001)
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
E Lagasse et al.
NATURE MEDICINE (2000)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)
A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector
C Demaison et al.
HUMAN GENE THERAPY (2000)
Share Paper
